NCT00141206 - A Twelve-Week Study of Varenicline for Safety and Efficacy in Comparison With Placebo and Zyban for Smoking Cessation | Biotech Hunter

Enrollment

1,005

Participants

Timeline

Start Date

May 31, 2003

Study Completion Date

April 30, 2005

Conditions

Smoking Cessation

Interventions

DRUG

varenicline (CP-526,555)

Trial Locations (20)

Pfizer Investigational Site, Tucson

Pfizer Investigational Site, Los Angeles

Pfizer Investigational Site, Newport Beach

Pfizer Investigational Site, Riverside

Pfizer Investigational Site, San Francisco

Pfizer Investigational Site, Upland

Pfizer Investigational Site, Farmington

Pfizer Investigational Site, Miami

Pfizer Investigational Site, Atlanta

Pfizer Investigational Site, Chicago

Pfizer Investigational Site, Lexington

Pfizer Investigational Site, New Orleans

Pfizer Investigational Site, Worcester

Pfizer Investigational Site, Omaha

Pfizer Investigational Site, Brooklyn

Pfizer Investigational Site, Great Neck

Pfizer Investigational Site, Portland

Pfizer Investigational Site, Philadelphia

Pfizer Investigational Site, Salt Lake City

Pfizer Investigational Site, Morgantown